{"id":2046333,"date":"2021-12-01T02:04:00","date_gmt":"2021-12-01T00:04:00","guid":{"rendered":"http:\/\/nhub.news\/?p=2046333"},"modified":"2021-12-01T05:27:30","modified_gmt":"2021-12-01T03:27:30","slug":"fda-panel-endorses-emergency-use-authorization-for-merck-covid-19-pill","status":"publish","type":"post","link":"http:\/\/nhub.news\/fr\/2021\/12\/fda-panel-endorses-emergency-use-authorization-for-merck-covid-19-pill\/","title":{"rendered":"FDA panel endorses emergency use authorization for Merck COVID-19 pill"},"content":{"rendered":"

A Food and Drug Administration advisory panel on Tuesday voted to endorse emergency use authorization for Merck’s experimental COVID-19 pill.<\/b>
\nNov.29 (UPI) — A Food and Drug Administration advisory panel on Tuesday voted to endorse Merck’s experimental COVID-19 pill. The Antimicrobial Drugs Advisory Committee voted 13-10 to recommend emergency use authorization for Merck’s molnupiravir oral capsules, the company announced.<\/p>\n